Biological Drugs for the Treatment of Moderate-to-Severe Psoriasis by Subcutaneous Route: Determining Statistical Equivalence According to Evidence-Based Methods
Crossref DOI link: https://doi.org/10.1007/s40261-014-0214-1
Published Online: 2014-06-28
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Messori, Andrea
Fadda, Valeria
Maratea, Dario
Trippoli, Sabrina
Gatto, Roberta
De Rosa, Mauro
Marinai, Claudio
Text and Data Mining valid from 2014-06-28